Visit Opsens at TCT 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at TCT 2019 (Transcatheter Cardiovascular Therapeutics 2019) by attending Opsens’ complimentary lunch  and educational symposium. Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with […]

Read More…

OPSENS – Q3 2019 – RECORD QUARTERLY FFR REVENUES OF $5.2 M, UP 49%

Quebec City, Quebec, July 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter of 2019. Highlights Consolidated revenues of $7.9 M for the third quarter of 2019 compared with $6.4 M for the third quarter of 2018, an increase of $1.5 M or 23%; Fractional […]

Read More…

Visit Opsens at CVI 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at CVI 2019 (Cardiovascular Innovations 2019) by attending Opsens’ complimentary lunch  and educational symposium. Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with […]

Read More…

OPSENS SOLUTIONS PARTNERS WITH TEMAI INGENIEROS FOR THE COMMISSIONING OF AN OPTICAL-BASED FUEL MONITORING SYSTEM FOR A MAJOR AIRCRAFT MANUFACTURER

Paris – Le Bourget, France, June 17, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that Opsens Solutions Inc. (“Opsens Solutions”), its wholly-owned subsidiary, is partnering with Temai Ingenieros S.L.  (“Temai”) for the commissioning of an optical-based fuel monitoring system for a major aircraft manufacturer. This agreement comes after over a […]

Read More…

OPSENS SOLUTIONS FURTHER EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH USPTO GRANT

Quebec City, Quebec, June 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that its wholly-owned subsidiary Opsens Solutions Inc. (“Opsens Solutions”), has been granted a patent for an innovative optical-based pressure sensor from the United States Patent and Trademark Office (“USPTO”). Patent no. 10,082,437 entitled “Optical Pressure Sensor with Reduced […]

Read More…

OPSENS TO PRESENT AT THE LD MICRO INVITATIONAL

Quebec City, Quebec, May 22, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a company focusing mainly on physiological measurements such as Fractional Flow Reserve (“FFR”) and Diastolic Pressure Ratio (“dPR”) in interventional cardiology, will present at the LD Micro 9th Invitational investor conference on Tuesday, June 4, 2019 at 8:40 am PST. Louis Laflamme, Opsens’ […]

Read More…

Visit Opsens at C3 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at the C3 2019 Conference by attending Opsens’ complimentary lunch  and educational symposium.  The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with confidence. Opsens second […]

Read More…

Visit Opsens at EuroPCR 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at EuroPCR 2019 by attending Opsens’ complimentary Case-In-Point session or visit Opsens at the exhibition: Booth #64, level 2. The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with […]

Read More…

This website uses cookies to ensure you get the best experience on our website.